Andalas University Develops PCR Raw Materials to Strengthen National Health Independence in line with SDG 3 (Good Health and Well-Being) and SDG 9 (Industry, Innovation and Infrastructure)

The development of PCR testing raw materials by researchers from the Faculty of Medicine at Andalas University represents a strategic effort to strengthen Indonesia’s health system and reduce dependency on imported medical technologies.

This innovation was introduced by a research team from the Faculty of Medicine, Andalas University, as part of the university’s commitment to advancing health research and supporting national resilience in diagnostic capabilities.

Currently, Indonesia still relies heavily on imported raw materials for PCR testing, which can create supply vulnerabilities, particularly during global health crises such as pandemics.

Through laboratory research conducted at Andalas University, the team successfully developed raw materials that can be used in PCR testing to detect infectious diseases more efficiently.

This innovation is expected to enhance domestic production capacity for diagnostic tools while also reducing testing costs and improving accessibility for healthcare services.

With this development, Andalas University reinforces its role as a key contributor in advancing medical innovation and strengthening national independence in healthcare technology.